Stay updated on Selpercatinib in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Selpercatinib in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Selpercatinib in Advanced Solid Tumors Clinical Trial page
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdded a note that PubMed publications shown on the page are automatically filled from PubMed and may not pertain to the study, and updated the page revision to v3.3.2; the previous PubMed note referencing v3.2.0 was removed.SummaryDifference0.0%

- Check26 days agoChange DetectedRemoved the government funding status notice banner from the page. The notice previously warned that information may not be up to date during funding lapses, and the page now presents only the study details.SummaryDifference0.2%

- Check49 days agoChange DetectedThe changes are limited to non-substantive UI adjustments on the Study Details page, with no edits to core trial information (eligibility, endpoints, or enrollment). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page now shows newer date values (2025-10-20, 2027-02, 2025-10-17, 2025-10) and removes older ones (2025-06-04, 2026-02, 2025-06-03, 2025-06). This suggests an update of time-sensitive information, with no indication of changes to core content, pricing, stock, or availability.SummaryDifference0.3%

- Check70 days agoChange Detected- Added a new Auvergne-Rhône-Alpes location entry and updated address to Lyon, Auvergne-Rhône-Alpes, France 69008; increased version to v3.2.0. - Removed the Rhône-Alpes location entry and specific resource for Medullary thyroid carcinoma. - Added a government funding notice and operating status information for NIH Clinical Center with links to cc.nih.gov and opm.gov.SummaryDifference2%

- Check77 days agoChange DetectedUpdated medical term to a streamlined name and bumped the revision to v3.1.0.SummaryDifference0.1%

Stay in the know with updates to Selpercatinib in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selpercatinib in Advanced Solid Tumors Clinical Trial page.